Open Access Highly Accessed Open Badges Research article

Microarray-based comparative genomic profiling of reference strains and selected Canadian field isolates of Actinobacillus pleuropneumoniae

Julien Gouré15, Wendy A Findlay2, Vincent Deslandes15, Anne Bouevitch2, Simon J Foote2, Janet I MacInnes3, James W Coulton45, John HE Nash26 and Mario Jacques15*

Author Affiliations

1 Groupe de Recherche sur les Maladies Infectieuses du Porc, Université de Montréal, St-Hyacinthe, Québec J2S 7C6, Canada

2 Institute for Biological Sciences, National Research Council of Canada, Ottawa, Ontario K1A 0R6, Canada

3 Department of Pathobiology, Ontario Veterinary College, University of Guelph, Guelph, Ontario N1G 2W1, Canada

4 Department of Microbiology and Immunology, McGill University, Montréal, Québec H3A 2B4, Canada

5 Centre de Recherche en Infectiologie Porcine, Université de Montréal, St-Hyacinthe, Québec J2S 7C6, Canada

6 Office of Biotechnology, Genomics and Population Health, Public Health Agency of Canada, Ottawa, Ontario K1A 0K9, Canada

For all author emails, please log on.

BMC Genomics 2009, 10:88  doi:10.1186/1471-2164-10-88

Published: 24 February 2009



Actinobacillus pleuropneumoniae, the causative agent of porcine pleuropneumonia, is a highly contagious respiratory pathogen that causes severe losses to the swine industry worldwide. Current commercially-available vaccines are of limited value because they do not induce cross-serovar immunity and do not prevent development of the carrier state. Microarray-based comparative genomic hybridizations (M-CGH) were used to estimate whole genomic diversity of representative Actinobacillus pleuropneumoniae strains. Our goal was to identify conserved genes, especially those predicted to encode outer membrane proteins and lipoproteins because of their potential for the development of more effective vaccines.


Using hierarchical clustering, our M-CGH results showed that the majority of the genes in the genome of the serovar 5 A. pleuropneumoniae L20 strain were conserved in the reference strains of all 15 serovars and in representative field isolates. Fifty-eight conserved genes predicted to encode for outer membrane proteins or lipoproteins were identified. As well, there were several clusters of diverged or absent genes including those associated with capsule biosynthesis, toxin production as well as genes typically associated with mobile elements.


Although A. pleuropneumoniae strains are essentially clonal, M-CGH analysis of the reference strains of the fifteen serovars and representative field isolates revealed several classes of genes that were divergent or absent. Not surprisingly, these included genes associated with capsule biosynthesis as the capsule is associated with sero-specificity. Several of the conserved genes were identified as candidates for vaccine development, and we conclude that M-CGH is a valuable tool for reverse vaccinology.